Allergic conjunctivitis is a disease characterised by inflammation of eyes due to an allergic reaction to substances such as pollen particles or mold spores. It is a collective term for eye infections such as seasonal allergic conjunctivitis (SAC), vernal keratoconjunctivitis (VKC), perennial allergic conjunctivitis (PAC), and atopic keratocongiuntivitis (AKC). Some of the most common forms of eye allergies are the SAC and PAC. According to a study published in the journal, Recent patents on inflammation and allergy drug discovery, these types of allergy are estimated to affect at least 15% to 20% of the global population. Allergic conjunctivitis could be acute (short-term) or chronic (lasts year-round) in nature. The most common symptom of the disease include swelling, itching, burning in eyes and light sensitivity. Allergic conjunctivitis is caused by allergens that trigger the release of histamine in the body. However, certain medications, contact lens solution or medicated eye drops may also cause Allergic conjunctivitis. Treatment involves a combination of prevention strategies and medications such as anti-inflammatory agents, antihistaminic agents and steroid eye drops.
The growth drivers for pipeline of allergic conjunctivitis include increasing market penetration of conjunctivitis medication due to mergers and acquisitions between major companies, rising demand for combination therapy due to superior efficacy, increasing exposure of to harmful pollutants and chemicals leading to an increase in prevalence of conjunctivitis globally and the rising awareness about the condition and the various treatment options available to treat the condition.
Request for Table of Content at: https://www.psmarketresearch.com/market-analysis/allergic-conjunctivitis-therapeutics-pipeline-analysis/toc-sample
Some of the major companies having a pipeline for Allergic Conjunctivitis include Ocular Therapeutix, Inc., Vistakon Pharmaceuticals, Aciex Therapeutics, Inc., C.T. Development America, Inc., Santen Pharmaceutical Co., Ltd., Bausch & Lomb Incorporated, Laboratorios Sophia S.A de C.V., Eleven Biotherapeutics, Alcon Research, Ltd., Ophthalmic Research Associates, Inc., Aldeyra Therapeutics, Inc., Senju USA, Inc., Mati Therapeutics Inc., Noveome Biotherapeutics, Inc., Akorn, Inc., Aciex Therapeutics, Inc., Shire plc, Fovea Pharmaceuticals SA, Sun Pharma Advanced Research Company Limited, Allergan plc, Eye Therapies, LLC, ORA, Inc., Merck Sharp & Dohme Corp., Woodmont Pharmaceuticals, Inc.
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY – 10016
Toll-free: +1-888-778-7886 (USA/Canada)